Amul's New Infant Formula Faces Criticism for Alleged IMS Act Violation

Amul's New Infant Formula Faces Criticism for Alleged IMS Act Violation

May 31, 2025

Amidst the launch of its new liquid infant formula, Amul is under fire from public health activists. They accuse the brand of breaching the Infant Milk Substitutes (IMS) Act by promoting a product that serves as a substitute for breastmilk. These activists have lodged complaints against Amul, arguing that the marketing and release of the formula go against the regulations that prohibit the endorsement of breastmilk alternatives. In response, Amul stands by its product, asserting that it adheres to the guidelines set forth by the IMS Act. The clash underscores the delicate balance between marketing strategies and the stringent laws aimed at protecting infant health and nutrition.

Read More at Economictimes

Tags: Amul, Public health activists, Ims act, Infant milk substitutes, Breastmilk substitutes,

Alejandro Roberie

Comments

Leave a reply

Your email address will not be published. Required fields are marked *